SPO Global. Inc., Provides a Shareholder Update
Press Release | 07/06/2020
SPO Global Inc (OTC: SPOM) CEO Lu Fengyu wants to update some company information to all shareholders. After three months negotiations, SPM Medical Co., Ltd. under Gerpang Healthcare Group will form a joint venture with Jinan Zhongke Xilai Medical Equipment Co., Ltd., a subsidiary of the Chinese Academy of Sciences, to establish the first stroke scientific research international hospital in Shandong Province. The hospital is located in Jinan High-tech Park to design 300 in-patient beds with a total investment of 300 million RMB yuan, the international hospital will intend to cooperate with North American universities to establish an international standard stroke prevention detection system, interventional treatment system & professional rehabilitation system. Jinan High-tech Park strongly supports the implementation of this innovative hospital project, which will bring new treatment and rehabilitation opportunities to stroke patients in Shandong and even China. This hospital is expected to launch in March next year.
About SPO Global
SPO Global Inc. (OTC Markets: SPOM) recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan high tech Zone. Its main business scope includes biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales.
Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
Company Contact:
fengyoulu@gmail.com
Source: SPO Global Inc.
Press Release | 07/06/2020
SPO Global Inc (OTC: SPOM) CEO Lu Fengyu wants to update some company information to all shareholders. After three months negotiations, SPM Medical Co., Ltd. under Gerpang Healthcare Group will form a joint venture with Jinan Zhongke Xilai Medical Equipment Co., Ltd., a subsidiary of the Chinese Academy of Sciences, to establish the first stroke scientific research international hospital in Shandong Province. The hospital is located in Jinan High-tech Park to design 300 in-patient beds with a total investment of 300 million RMB yuan, the international hospital will intend to cooperate with North American universities to establish an international standard stroke prevention detection system, interventional treatment system & professional rehabilitation system. Jinan High-tech Park strongly supports the implementation of this innovative hospital project, which will bring new treatment and rehabilitation opportunities to stroke patients in Shandong and even China. This hospital is expected to launch in March next year.
About SPO Global
SPO Global Inc. (OTC Markets: SPOM) recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan high tech Zone. Its main business scope includes biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales.
Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
Company Contact:
fengyoulu@gmail.com
Source: SPO Global Inc.
